Sosei Heptares to Present at 42nd Annual J.P. Morgan
Tokyo, Japan and Cambridge, UK, 21 December 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565), announces its President &...
Source: globenewswire.com
Page 2 - Sosei Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sosei Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sosei Group Today - Breaking & Trending Today
Sosei Group Announces Marketing Approval for PIVLAZ™ (clazosentan sodium) 150 mg in South Korea
PIVLAZ™, a new drug for prevention of Cerebral Vasospasm in patients with Aneurysmal Subarachnoid Hemorrhage (aSAH), approved in South KoreaPIVLAZ...
Source: businessinsider.com
Sosei Group Corporation Announces Marketing Approval for PIVLAZ (Clazosentan Sodium) 150 Mg in South Korea
Sosei Group Corporation announced that PIVLAZ 150 mg has received marketing approval from the Ministry of Food and Drug Safety in South Korea for the prevention of cerebral vasospasm,...
Source: marketscreener.com
Sosei Heptares to Regain Full Ownership of GSK4381406*, a
GPR35 is a novel target with an established genetic association to IBDUK regulatory approval received to commence first-in-human studiesIndependent...
Source: globenewswire.com
Sosei Heptares Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2023
Tokyo, Japan and Cambridge, UK, 10 November 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the third quarter and nine months ended 30 September 2023. The full report can be found by clicking here. Chris Cargill, President & CEO of Sosei Heptares, commented: “The third quarter has been an exciting and transformational period for the Group following the acquisition of Idorsia’s phar
Source: yahoo.com